{
  "trial_id": "NCT01222689",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, ECOG performance status, prior lines of therapy, absolute neutrophil count (ANC), platelet count, total bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), serum creatinine, CA19-9 levels, life expectancy, presence of measurable disease, prior radiation therapy, use of contraception, pregnancy status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status",
          "ECOG performance status"
        ],
        [
          "Prior chemotherapy",
          "prior lines of therapy"
        ],
        [
          "Prior radiation",
          "prior radiation therapy"
        ],
        [
          "Elevated baseline Cancer Antigen 19-9(CA19-9) > 2x Upper Limit of Normal (ULN)",
          "CA19-9 levels"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Prior surgery"
      ],
      "remaining_candidate_features": [
        "race",
        "absolute neutrophil count (ANC)",
        "platelet count",
        "total bilirubin",
        "aspartate aminotransferase (AST)",
        "alanine aminotransferase (ALT)",
        "serum creatinine",
        "life expectancy",
        "presence of measurable disease",
        "use of contraception",
        "pregnancy status"
      ]
    },
    "processed-gen-response": "Age, gender, race, ECOG performance status, prior lines of therapy, absolute neutrophil count (ANC), platelet count, total bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), serum creatinine, CA19-9 levels, life expectancy, presence of measurable disease, prior radiation therapy, use of contraception, pregnancy status."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, ECOG performance status, Absolute neutrophil count, Platelet count, Total bilirubin, AST, ALT, Serum creatinine, CA19-9 level, Prior systemic therapy, Prior radiation therapy, Life expectancy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Prior chemotherapy",
          "Prior systemic therapy"
        ],
        [
          "Prior radiation",
          "Prior radiation therapy"
        ],
        [
          "Elevated baseline Cancer Antigen 19-9(CA19-9) > 2x Upper Limit of Normal (ULN)",
          "CA19-9 level"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status",
          "ECOG performance status"
        ]
      ],
      "remaining_reference_features": [
        "Region of Enrollment",
        "Prior surgery"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Absolute neutrophil count",
        "Platelet count",
        "Total bilirubin",
        "AST",
        "ALT",
        "Serum creatinine",
        "Life expectancy"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, ECOG performance status, Absolute neutrophil count, Platelet count, Total bilirubin, AST, ALT, Serum creatinine, CA19-9 level, Prior systemic therapy, Prior radiation therapy, Life expectancy"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Prior Chemotherapy, Prior Radiation Therapy, CA19-9 Level, Tumor Stage, Tumor Location, ANC, Platelet Count, INR, Total Bilirubin, AST, ALT, Serum Creatinine.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Prior chemotherapy",
          "Prior Chemotherapy"
        ],
        [
          "Prior radiation",
          "Prior Radiation Therapy"
        ],
        [
          "Elevated baseline Cancer Antigen 19-9(CA19-9) > 2x Upper Limit of Normal (ULN)",
          "CA19-9 Level"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status",
          "ECOG Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Prior surgery"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Tumor Stage",
        "Tumor Location",
        "ANC",
        "Platelet Count",
        "INR",
        "Total Bilirubin",
        "AST",
        "ALT",
        "Serum Creatinine"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Prior Chemotherapy, Prior Radiation Therapy, CA19-9 Level, Tumor Stage, Tumor Location, ANC, Platelet Count, INR, Total Bilirubin, AST, ALT, Serum Creatinine."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, ECOG performance status, life expectancy, histological type of pancreatic cancer, number of prior therapies, prior radiation therapy, prior surgery, CA19-9 level, ANC, platelet count, INR, total bilirubin, AST, ALT, serum creatinine, presence of metastases, measurable disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status",
          "ECOG performance status"
        ],
        [
          "Prior chemotherapy",
          "number of prior therapies"
        ],
        [
          "Prior surgery",
          "prior surgery"
        ],
        [
          "Prior radiation",
          "prior radiation therapy"
        ],
        [
          "Elevated baseline Cancer Antigen 19-9(CA19-9) > 2x Upper Limit of Normal (ULN)",
          "CA19-9 level"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "life expectancy",
        "histological type of pancreatic cancer",
        "ANC",
        "platelet count",
        "INR",
        "total bilirubin",
        "AST",
        "ALT",
        "serum creatinine",
        "presence of metastases",
        "measurable disease"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, ECOG performance status, life expectancy, histological type of pancreatic cancer, number of prior therapies, prior radiation therapy, prior surgery, CA19-9 level, ANC, platelet count, INR, total bilirubin, AST, ALT, serum creatinine, presence of metastases, measurable disease."
  }
}